Compare PYPD & FNWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PYPD | FNWB |
|---|---|---|
| Founded | 2008 | 1923 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.8M | 69.1M |
| IPO Year | 2020 | 2015 |
| Metric | PYPD | FNWB |
|---|---|---|
| Price | $3.85 | $9.81 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | $12.00 | ★ $13.50 |
| AVG Volume (30 Days) | ★ 67.8K | 21.6K |
| Earning Date | 11-12-2025 | 10-27-2025 |
| Dividend Yield | N/A | ★ 1.42% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $54,052,000.00 |
| Revenue This Year | N/A | $33.26 |
| Revenue Next Year | N/A | $10.68 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 6.47 |
| 52 Week Low | $2.30 | $6.05 |
| 52 Week High | $3.96 | $12.10 |
| Indicator | PYPD | FNWB |
|---|---|---|
| Relative Strength Index (RSI) | 67.95 | 73.44 |
| Support Level | $3.50 | $9.69 |
| Resistance Level | $3.69 | $10.00 |
| Average True Range (ATR) | 0.14 | 0.22 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 94.80 | 87.84 |
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.